The histidine phosphatase LHPP: an emerging player in cancer

References

• Boyer PD, DeLuca M, Ebner KE, et al. Identification of phosphohistidine in digests from a probable intermediate of oxidative phosphorylation. J Biol Chem. 1962;237(10): Pc3306–pc3308.
   Web of Science ®Google Scholar
• Tan E, Besant PG, and Zu XL, et al. Histone H4 histidine kinase displays the expression pattern of a liver oncodevelopmental marker. Carcinogenesis. 2004;25(11):2083–2088.
   PubMed Web of Science ®Google Scholar
• Attwood PV, Muimo R. The actions of NME1/NDPK-A and NME2/NDPK-B as protein kinases. Lab Invest. 2018;98(3):283–290.
   PubMed Web of Science ®Google Scholar
• Boissan M, Schlattner U, Lacombe M-L. The NDPK/NME superfamily: state of the art. Lab Invest. 2018;98(2):164–174.
   PubMed Web of Science ®Google Scholar
• Andolfo I, De Martino D, Liguori L, et al. Correlation of NM23-H1 cytoplasmic expression with metastatic stage in human prostate cancer tissue. Naunyn Schmiedebergs Arch Pharmacol. 2011;384(4–5):489–498.
   PubMed Web of Science ®Google Scholar
• Gong Y, Yang G, Wang Q, et al. NME2 Is a Master Suppressor of Apoptosis in Gastric Cancer Cells via Transcriptional Regulation of miR-100 and Other Survival Factors. Mol Cancer Res. 2020;18(2):287–299.
   PubMed Web of Science ®Google Scholar
• Fuhs SR, Hunter T. pHisphorylation: the emergence of histidine phosphorylation as a reversible regulatory modification. Curr Opin Cell Biol. 2017;45:8–16.
   PubMed Web of Science ®Google Scholar
• Ek P, Pettersson G, Ek B, et al. Identification and characterization of a mammalian 14-kDa phosphohistidine phosphatase. Eur J Biochem. 2002;269(20):5016–5023.
   PubMedGoogle Scholar
• Klumpp S, Bechmann G, Mäurer A, et al. ATP-citrate lyase as a substrate of protein histidine phosphatase in vertebrates. Biochem Biophys Res Commun. 2003;306(1):110–115.
   PubMed Web of Science ®Google Scholar
• Klumpp S, Hermesmeier J, Selke D, et al. Protein histidine phosphatase: a novel enzyme with potency for neuronal signaling. J Cereb Blood Flow Metab. 2002;22(12):1420–1424.
   PubMed Web of Science ®Google Scholar
• Mäurer A, Wieland T, Meissl F, et al. The beta-subunit of G proteins is a substrate of protein histidine phosphatase. Biochem Biophys Res Commun. 2005;334(4):1115–1120.
   PubMed Web of Science ®Google Scholar
• Tian T, Hao J, Xu A, et al. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci. 2007;98(8):1265–1274.
   PubMed Web of Science ®Google Scholar
• Xu A, Hao J, Zhang Z, et al. 14-kDa phosphohistidine phosphatase and its role in human lung cancer cell migration and invasion. Lung Cancer. 2010;67(1):48–56.
   PubMed Web of Science ®Google Scholar
• Han SX, Wang L-J, Zhao J, et al. 14-kDa Phosphohistidine phosphatase plays an important role in hepatocellular carcinoma cell proliferation. Oncol Lett. 2012;4(4):658–664.
   PubMed Web of Science ®Google Scholar
• Shen H, Yang P, Liu Q, et al. Nuclear expression and clinical significance of phosphohistidine phosphatase 1 in clear-cell renal cell carcinoma. J Int Med Res. 2015;43(6):747–757.
   PubMed Web of Science ®Google Scholar
• Lu W, Karuppagounder SS, Springer DA, et al. Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder. Nat Commun. 2014;5(1):4930.
   PubMedGoogle Scholar
• Ma K, Zhang Z, Chang R, et al. Dynamic PGAM5 multimers dephosphorylate BCL-xL or FUNDC1 to regulate mitochondrial and cellular fate. Cell Death Differ. 2020;27(3):1036–1051.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jiang H, Chen S, et al. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell. 2012;148(1–2):228–243.
   PubMed Web of Science ®Google Scholar
• Cheng J, Qian D, Ding X, et al. High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patients. Cell Death Dis. 2018;9(10):991.
   PubMedGoogle Scholar
• Cui L, Gong X, Tang Y, et al. Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder. Neural Plast. 2016;2016:9162590.
   PubMed Web of Science ®Google Scholar
• Seal US, Binkley F. An inorganic pyrophosphatase of swine brain. J Biol Chem. 1957;228(1):193–199.
   PubMed Web of Science ®Google Scholar
• Peng R, Li Y. Low serum thyroid-stimulating hormone levels are associated with lipid profile in depressive patients with long symptom duration. J Affect Disord. 2017;217:99–104.
   PubMed Web of Science ®Google Scholar
• Cui L, Gong X, Chang M, et al. Association of LHPP genetic variation (rs35936514) with structural and functional connectivity of hippocampal-corticolimbic neural circuitry. Brain Imaging and Behavior. 2020;14(4):1025–1033.
   PubMed Web of Science ®Google Scholar
• Knowles EEM, Kent JW, McKay DR, et al. Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression. J Affect Disord. 2016;191:123–131.
   PubMed Web of Science ®Google Scholar
• Chao X, Zhang W, Wu J, et al. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Biomed Res Int. 2021;2021:1971048.
   PubMedGoogle Scholar
• Zhang X, Kang H, Xiao J, et al. LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma. Biomed Res Int. 2020;2020:7020924.
   PubMed Web of Science ®Google Scholar
• Hindupur SK, Colombi M, Fuhs SR, et al. The protein histidine phosphatase LHPP is a tumour suppressor. Nature. 2018;555(7698):678–682.
   PubMed Web of Science ®Google Scholar
• Chen W-J, Chen L-H, Wang J, et al. LHPP impedes energy metabolism by inducing ubiquitin-mediated degradation of PKM2 in glioblastoma. Am J Cancer Res. 2021;11(4):1369–1390.
   PubMed Web of Science ®Google Scholar
• Li C, Yang J, Wang W, et al. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling. J Bioenerg Biomembr. 2021;53(1):61–71.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang X, and Zhou X, et al. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway. Biosci Rep. 2019;39(7). DOI:https://doi.org/10.1042/BSR20182270
   Google Scholar
• Liao L, Duan D, Liu Y, et al. LHPP inhibits hepatocellular carcinoma cell growth and metastasis. Cell Cycle. 2020;19(14):1846–1854.
   PubMed Web of Science ®Google Scholar
• Sun W, Qian K, Guo K, et al. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway. Acta Biochim Biophys Sin (Shanghai). 2020;52(4):382–389.
   PubMed Web of Science ®Google Scholar
• Wang D, Ning Z, Zhu Z, et al. LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibiting the TGFβ/smad signaling pathway. Int J Biochem Cell Biol. 2021;132:105845.
   PubMed Web of Science ®Google Scholar
• Wu F, Chen Y, and Zhu J. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer. Biosci Rep. 2020;40(3). DOI:https://doi.org/10.1042/BSR20194142
   Google Scholar
• Hou B, Li W, Li J, et al. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway. Oncol Rep. 2020;43(2):536–548.
   PubMed Web of Science ®Google Scholar
• Yu T, Han C, Zhu G, et al. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma. Cancer Med. 2017;6(7):1587–1600.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.
   PubMed Web of Science ®Google Scholar
• Schulze K, Imbeaud S, Letouzé E, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47(5):505–511.
   PubMed Web of Science ®Google Scholar
• Yan J, He L, Li G, et al. Clinical Value of Serum LHPP-associated miR-765 in the Prognosis of Laparoscopic or Open Hepatectomy for Hepatocellular Carcinoma. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 2020;30(5):395–402.
   PubMed Web of Science ®Google Scholar
• Tian Z, Yu T, Wei H, et al. Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma. J Clin Lab Anal. 2020;34(2):e23071.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Bahrami A, Khazaei M, Hasanzadeh M, et al. Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: rational and Progress. J Cell Biochem. 2018;119(3):2460–2469.
   PubMed Web of Science ®Google Scholar
• Noorolyai S, Shajari N, Baghbani E, et al. The relation between PI3K/AKT signalling pathway and cancer. Gene. 2019;698:120–128.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhou X, Zhu H, et al. Purpurin binding interacts with LHPP protein that inhibits PI3K/AKT phosphorylation and induces apoptosis in colon cancer cells HCT-116. J Biochem Mol Toxicol. 2021;35(3):e22665.
   PubMed Web of Science ®Google Scholar
• Pan M-H, Lai C-S, Wu J-C, et al. Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res. 2011;55(1):32–45.
   PubMed Web of Science ®Google Scholar
• Perše M. Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? Biomed Res Int. 2013;2013:725710.
   PubMed Web of Science ®Google Scholar
• Hou B, Li W, Xia P, et al. LHPP suppresses colorectal cancer cell migration and invasion in vitro and in vivo by inhibiting Smad3 phosphorylation in the TGF-β pathway. Cell Death Discov. 2021;7(1):273.
   PubMed Web of Science ®Google Scholar
• Chen R, Sheng L, Zhang H-J, et al. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer. J Cell Mol Med. 2018;22(3):1855–1863.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin H-R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917.
   PubMed Web of Science ®Google Scholar
• Poorthuis MHF, Vernooij RWM, van Moorselaar RJA, et al. Second-line therapy in patients with metastatic castration-resistant prostate cancer with progression after or under docetaxel: a systematic review of nine randomized controlled trials. Semin Oncol. 2017;44(5):358–371.
   PubMed Web of Science ®Google Scholar
• Du H, Zhao Y, He J, et al. YTHDF2 destabilizes m6A-containing RNA through direct recruitment of the CCR4–NOT deadenylase complex. Nat Commun. 2016;7(1):12626.
   PubMedGoogle Scholar
• Wang H, Zuo H, Liu J, et al. Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration. Cell Res. 2018;28(10):1035–1038.
   PubMed Web of Science ®Google Scholar
• Wang X, Lu Z, Gomez A, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117–120.
   PubMed Web of Science ®Google Scholar
• Yang Z, Li J, Feng G, et al. MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein. J Biol Chem. 2017;292(9):3614–3623.
   PubMed Web of Science ®Google Scholar
• Li J, Xie H, Ying Y, et al. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Mol Cancer. 2020;19(1):152.
   PubMed Web of Science ®Google Scholar
• Lin Q, Cai J, Wang -Q-Q. The Significance of Circular RNA DDX17 in Prostate Cancer. Biomed Res Int. 2020;2020:1878431.
   PubMed Web of Science ®Google Scholar
• Boele FW, Given CW, Given BA, et al. Family caregivers‘ level of mastery predicts survival of patients with glioblastoma: a preliminary report. Cancer. 2017;123(5):832–840.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. Neuro Oncol. 2019;21(Suppl Supplement_5):v1–v100.
   PubMedGoogle Scholar
• McCord M, Mukouyama Y-S, Gilbert MR, et al. Targeting WNT Signaling for Multifaceted Glioblastoma Therapy. Front Cell Neurosci. 2017;11:318.
   PubMed Web of Science ®Google Scholar
• Zhong Z, Yu J, Virshup DM, et al. Wnts and the hallmarks of cancer. Cancer Metastasis Rev. 2020;39(3):625–645.
   PubMed Web of Science ®Google Scholar
• Tewari KS, Sill MW, Long HJ, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370(8):734–743.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–384. DOI:https://doi.org/10.1038/nature21386
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Zhu L, Zhu L, Shi H, et al. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging. BMC Cancer. 2016;16(1):79.
   PubMedGoogle Scholar
• Zheng J, Dai X, Chen H, et al. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT. Biochem Biophys Res Commun. 2018;503(2):1108–1114.
   PubMed Web of Science ®Google Scholar
• Peurala E, Koivunen P, Haapasaari K-M, et al. The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer. Breast Cancer Res. 2013;15(1):R5.
   PubMed Web of Science ®Google Scholar
• Yadav V, Sultana S, Yadav J, et al. Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53. PLoS One. 2012;7(10):e47796.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013;2013:965212.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29.
   PubMed Web of Science ®Google Scholar
• Lei Y, Zhang D, Yu J, et al. Targeting autophagy in cancer stem cells as an anticancer therapy. Cancer Lett. 2017;393:33–39.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542.
   PubMed Web of Science ®Google Scholar
• Feng Z. p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol. 2010;2(2):a001057.
   PubMed Web of Science ®Google Scholar
• Pollard C, Smith SC, Theodorescu D. Molecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC). Expert Rev Mol Med. 2010;12:e10.
   PubMed Web of Science ®Google Scholar
• Rosenberg JE, Hahn WC. Bladder cancer: modeling and translation: table 1. Genes Dev. 2009;23(6):655–659.
   PubMed Web of Science ®Google Scholar
• Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Hsu PP, Sabatini DM. Cancer cell metabolism: warburg and beyond. Cell. 2008;134(5):703–707.
   PubMed Web of Science ®Google Scholar
• Maeda S, Kamata H, Luo J-L, et al. IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis. Cell. 2005;121(7):977–990.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Karin M. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18(5):309–324.
   PubMed Web of Science ®Google Scholar
• Ding Z, Yu D, Li H, et al. Prognostic Correlation of Glycolysis-Related Gene Signature in Patients with Laryngeal Cancer. Am J Med Sci. 2021;362(2):161–172.
   PubMed Web of Science ®Google Scholar
• Meng K, Li Z, Cui X. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients. J Clin Lab Anal. 2021;35(12):e24077.
   PubMed Web of Science ®Google Scholar
• Yang X, Meng L, Zhong Y, et al. The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis. Aging (Albany NY). 2021;13(2):2864–2884.
   PubMedGoogle Scholar
• Li J, Huang H, Li Y, et al. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer. Oncol Rep. 2016;36(6):3241–3250.
   PubMed Web of Science ®Google Scholar
• Tan Q, Zuo J, Qiu S, et al. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker. Int J Oncol. 2017;50(5):1729–1738.
   PubMed Web of Science ®Google Scholar
• Wang T-H, Chan C-W, Fang J-Y, et al. 2-O-Methylmagnolol upregulates the long non-coding RNA, GAS5, and enhances apoptosis in skin cancer cells. Cell Death Dis. 2017;8(3):e2638.
   PubMedGoogle Scholar
• Xue Y, Ni T, Jiang Y, et al. Long Noncoding RNA GAS5 Inhibits Tumorigenesis and Enhances Radiosensitivity by Suppressing miR-135b Expression in Non-Small Cell Lung Cancer. Oncol Res. 2017;25(8):1305–1316.
   PubMed Web of Science ®Google Scholar
• Bai M, Zhang M, Long F, et al. MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF. Am J Transl Res. 2017;9(2):647–655.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Xiong M, Liu J, et al. <p>Targeted nanoparticle-mediated LHPP for melanoma treatment. Int J Nanomedicine. 2019;14:3455–3468.
   PubMed Web of Science ®Google Scholar
• Yang HD, Kim P-J, Eun JW, et al. Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer. Oncotarget. 2016;7(10):11412–11423.
   PubMedGoogle Scholar
• Chou J, Quigley DA, Robinson TM, et al. Transcription-Associated Cyclin-Dependent Kinases as Targets and Biomarkers for Cancer Therapy. Cancer Discov. 2020;10(3):351–370.
   PubMed Web of Science ®Google Scholar
• Kim KH, Roberts CWM. Targeting EZH2 in cancer. Nat Med. 2016;22(2):128–134.
   PubMed Web of Science ®Google Scholar